Organ support & nutrition

Association of RBC Transfusion Thresholds and Outcomes in Medical Patients With Acute Respiratory Failure Supported With Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Cohort Study

ChestPublished Retrospective cohort study

Authors' conclusion

We observed a decrease in number of RBC units per day of ECMO over time, but changes were not associated temporally with implementation of transfusion thresholds. A transfusion threshold of hemoglobin < 8 g/dL was associated with a lower hazard of death, but these findings are limited by study methodology.

Study context

Population
Medical patients with acute respiratory failure receiving venovenous extracorporeal membrane oxygenation (ECMO)
Participants
229 patients
Exposure
No threshold vs Hemoglobin < 7 g/dL
  • No thresholdn = 91
  • Hemoglobin < 8 g/dLn = 48reference
  • Hemoglobin < 7 g/dLn = 90
Outcome
Trends in RBC use (number of RBC units transfused per day of ECMO support)
Methodological detailssingle-centre, segmented regression
  • Single-centre
  • Segmented regression

Main finding

As reported in the abstract

RBC units transfused per day of ECMO support

No threshold

0.6

mean · SD 1.0

Hemoglobin < 8 g/dL

0.3

mean · SD 0.8

Hemoglobin < 7 g/dL

0.3

mean · SD 1.1

P < 0.001

Observational data: associations, not effects.

Secondary outcomes

OutcomeaHR (95% CI)
Hazard of death (in-hospital)No threshold vs Hemoglobin < 8 g/dL2.08 (1.12–3.88)
Hazard of death (in-hospital)Hemoglobin < 7 g/dL vs Hemoglobin < 8 g/dL1.93 (1.02–3.62)
Hazard of death (in-hospital)No threshold vs Hemoglobin < 7 g/dL1.08 (0.69–1.69)

Original publication

Association of RBC Transfusion Thresholds and Outcomes in Medical Patients With Acute Respiratory Failure Supported With Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Cohort Study. Chest. Published 8 July 2024. doi:10.1016/j.chest.2024.05.043

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.